A Clinical Intervention Study of Tangningtongluo on Diabetic Foot Ulcer
Purpose and significance:With the increasing incidence of Diabetes mellitus (DM), the incidence rate of Diabetic Foot (DF) is raised. DF is a foot infection, ulceration and / or deep tissue destruction caused by nerve abnormalities and varying degrees of vascular lesions in DM patients. The high incidence, disability and mortality rate of DF make it urgent to explore new ways to improve the cure rate, reduce the burden and elevate the quality of life. Previous studies have confirmed that traditional Miao ethic medicine Tangningtongluo(TNTL) can improve the remission rate of diabetes mellitus and diabetic foot disease, but the clinical research evidence is not sufficient. This study aims to provide effective clinical evidence for the treatment of diabetic foot patients with TNTL by observing growth rate of wound, prognosis and outcome.
Methods: From September 2021 to March 2023, a total of 80 diabetic foot ulcer patients admitted to Department of Endocrinology and Metabolism at the Affiliated Hospital of Nantong University were recruited. Participants are randomized in a ratio of 1: 1: 1:1 into four treatment groups of 20 participants: (i) standardized western medicine treatment group, (ii) standardized western medicine treatment+TNTL tablet+TNTL cream group , (iii) standardized western medicine treatment+TNTL tablet group, and (iiii) standardized western medicine treatment+TNTL cream group. Treatment with TNTL tablets: the oral administration of TNTL tablets, 4 tablets each time, 3 times a day. Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing. Anthropometric parameters, serum biochemical index, glycosylated hemoglobin, urinary microalbumin/creatinine ratio, islet-specific autoantibodies(ISAs), fat mass, and islet β-cell function were measured. The healing stage of the wound surface and the growth degree of granulation tissue were graded, and the time required for wound repairing to each healing stage was observed.
Type of study: randomized controlled, prospective,intervention study.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Tipo di studio
Iscrizione (Anticipato)
Fase
- Fase 1
Contatti e Sedi
Luoghi di studio
-
-
Jiangsu
-
Nantong, Jiangsu, Cina, 226001
- Reclutamento
- Gu Yunjuan
-
Contatto:
- Gu Yunjuan, M.D/Ph.D
- Numero di telefono: +8615851207860
- Email: desette@ntu.edu.cn
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Clinical diagnosis of Type 2 diabetes mellitus
- Clinical diagnosis of Diabetic Foot Ulcer
Exclusion Criteria:
- Type 1 diabetes mellitus(T1DM), special type of diabetes, gestational diabetes mellitus, drug-induced hyperglycemia
- TNTL allergy
- Chronic kidney failure（eGFR≤30ml/min/1.73cm2）, severe liver function damage (transaminase ≥ 3 times the normal value), acute or chronic pancreatitis, autoimmune disease, malignant tumors
- Recent acute complications of type 2 diabetes mellitus（ketoacidosis, hyperosmolar nonketotic diabetic coma, lactic acidosis etc.）or other emergency situations
- History of using glucocorticoids and immunosuppressants
- Mental illness and cognitive dysfunction or poor compliance, unable to take medication as required
- Malignant ulcer
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Standardized Western Medicine Treatment Group
All participants undergo a similar treatment protocol for the diabetic foot, based on the Infectious Diseases Society of America (IDSA).
|
Standardized Western Medicine Treatment includes hypoglycemic, debridement and anti infection treatments.
Altri nomi:
|
|
Sperimentale: Standardized Western Medicine Treatment +TNTL tablet+TNTL cream Group
Treatment with TNTL tablets:the oral administration of TNTL tablets, 4 tablets each time, 3 times a day.
Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing.
|
Standardized Western Medicine Treatment includes hypoglycemic, debridement and anti infection treatments.
Altri nomi:
Tangningtongluo(TNTL) , a traditional botanical ethnic medicine, composed of plantain, honeysuckle, agrimony, etc.
It is famous for its effects of promoting blood circulation, dredging collaterals, reducing thirst and lowering glucose.There are two dosage forms: tablet and cream.
Altri nomi:
|
|
Sperimentale: Standardized Western Medicine Treatment +TNTL tablet Group
Treatment with TNTL tablets:the oral administration of TNTL tablets, 4 tablets each time, 3 times a day.
|
Standardized Western Medicine Treatment includes hypoglycemic, debridement and anti infection treatments.
Altri nomi:
Tangningtongluo(TNTL) , a traditional botanical ethnic medicine, composed of plantain, honeysuckle, agrimony, etc.
It is famous for its effects of promoting blood circulation, dredging collaterals, reducing thirst and lowering glucose.The participants in this arm use tablet.
Altri nomi:
|
|
Sperimentale: Standardized Western Medicine Treatment +TNTL cream Group
Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing.
|
Standardized Western Medicine Treatment includes hypoglycemic, debridement and anti infection treatments.
Altri nomi:
Tangningtongluo(TNTL) , a traditional botanical ethnic medicine, composed of plantain, honeysuckle, agrimony, etc.
It is famous for its effects of promoting blood circulation, dredging collaterals, reducing thirst and lowering glucose.The participants in this arm use cream.
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Decrease area of wound healing due to Diabetic Foot Ulcer
Lasso di tempo: 12 weeks
|
Assessment the decrease of whole area of diabetic foot ulcers.
The unit is square centimeters .
|
12 weeks
|
|
Decrease of depth of ulcer involve the deep fascia.
Lasso di tempo: 12 weeks
|
Measurement of depth of ulcer involve the deep fascia.
The unit is millimeters.
|
12 weeks
|
|
Amputation Rate
Lasso di tempo: 12 weeks
|
The difference of end-stage amputation rates between the experimental group and the control group were evaluated by the arterial and venous blood circulation of the lower limbs
|
12 weeks
|
|
Diabetic Foot Ulcer relapse rate
Lasso di tempo: 12 weeks
|
The relapse of Diabetic Foot Ulcers is a common complication in the advanced stage of DFU.
The difference of treatment between the experimental group and the control group indicates that the prognosis is variability.
|
12 weeks
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Fasting glucose
Lasso di tempo: 12 weeks
|
10 hours after fasting peripheral blood glucose level, and the unit is mmol/L
|
12 weeks
|
|
2-H postload glucose
Lasso di tempo: 12 weeks
|
2 hours after peripheral blood glucose level eating 75g glucose or 100g steamed bread, and the unit is mmol/L
|
12 weeks
|
|
BMI Index
Lasso di tempo: 12 weeks
|
The calculation formula of Body Mass Index is: BMI = weight ÷ height 2. (weight in kilograms; height in meters.)
|
12 weeks
|
|
WHR Index
Lasso di tempo: 12 weeks
|
Waist to hip ratio (WHR) = waist / hip.Waist circumference or minimum waist circumference shall be used for measurement, and evaluation of WHR is an important value to central obesity.
|
12 weeks
|
|
Islet B cell function
Lasso di tempo: 12 weeks
|
The ability of islet B cells to secrete insulin was reflected by the level of C peptide, which is measured after fasting.
The unit is ng/dL .
|
12 weeks
|
|
interleukin-6(IL-6)
Lasso di tempo: 12 weeks
|
Determine the level of interleukin-6(IL-6) in peripheral blood by ELISA, the unit is ng/L.
|
12 weeks
|
|
tumour necrosis factor-α(TNF-α)
Lasso di tempo: 12 weeks
|
Determine the level of TNF-α in peripheral blood , the unit is ng/ml.
|
12 weeks
|
|
C-reactive protein(CRP)
Lasso di tempo: 12 weeks
|
Determine the level of C-reactive protein(CRP) in peripheral blood , the unit is μg/L.
|
12 weeks
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- TNTL on diabetic foot ulcer
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Ulcera del piede diabetico
-
The General Authority for Teaching Hospitals and...ReclutamentoGestione | Denis Brawn Brace | Modifica | Foot club idiopatico | Casting PonsetiEgitto
-
Biocomposites LtdA disposizioneOsteomielite del piede diabetico | Fase IV Ulcer a pressione